A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial

Published:2014-02-21 Issue:5 Volume:89 Page:536-541
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Hertzberg Mark¹,Matthews Jane Palfrey²,Stone Janey Malka³,Dubosq Ming-Celine¹,Grigg Andrew⁴,Ellis David⁵,Benson Warwick¹,Browett Peter⁶,Horvath Noemi⁷,Januszewicz Henry⁸,Abdi Ehtesham⁹,Green Michael¹⁰,Bonaventura Anthony¹¹,Marlton Paula¹²,Cannell Paul¹³,Wolf Max⁸,

Affiliation:

1. Department of Haematology; Westmead Hospital; Westmead Australia

2. Center for Biostatistics and Clinical Trials, Peter MacCallum Cancer Center; Melbourne Australia

3. ALLG Operations Unit; Melbourne Australia

4. Department of Clinical Haematology; Austin Hospital; Heidelberg Australia

5. SA Pathology; Frome Road Adelaide Australia

6. Department of Molecular Medicine and Pathology; University of Auckland, Auckland Hospital; Auckland New Zealand

7. Department of Haematology; Royal Adelaide Hospital; Adelaide Australia

8. Division of Haematology and Medical Oncology; Peter MacCallum Cancer Centre; Melbourne Australia

9. Griffith University Gold Coast; Southport Australia

10. Department of Clinical Haematology and Medical Oncology; Western Health; Footscray Australia

11. Department of Medical Oncology; Calvary Mater Hospital; Newcastle Australia

12. Department of Haematology Princess Alexandra Hospital; Brisbane; Australia and School of Medicine; University of Queensland; Brisbane Australia

13. Department of Haematology; Royal Perth Hospital; Perth Australia

Funder

Pharmacia Pty Ltd (now Pfizer Australia)

Amgen Australia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23684/fullpdf

Reference26 articles.

1. A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993

2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Engl J Med,1993

3. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma;Cooper;J Clin Oncol,1994

4. Survival of diffuse large cell lymphoma: A multivariate analysis including dose intensity variables;Epelbaum;Cancer,1990

5. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis;Kwak;J Clin Oncol,1990

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up‐front autologous stem cell transplant in peripheral T‐cell lymphoma patients achieving complete response after first‐line treatment: A multicentre real‐world analysis;British Journal of Haematology;2024-01-25

2. Multiple cerebral lesions in a patient with refractory celiac disease: A case report;World Journal of Gastroenterology;2020-12-21

3. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review;The Lancet Haematology;2020-12

4. CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial;Genome Medicine;2020-04-30

5. Use of epirubicin to treat diffuse large B-cell lymphoma;The Lancet Haematology;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3